Supported by

TAVI (Transcatheter aortic valve implantation)

Latest TAVI content in interventional cardiology - research, practice, and education

TAVI, now an established, valid treatment for patients presenting with symptomatic severe aortic stenosis, has proven to be superior to medical treatment for inoperable patients whilst being a valid alternative to surgery in select, high-risk patients. This topic covers the newest devices and emerging data in TAVI as well as information on tools, devices and techniques such as vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography, understanding bleeding risks or patient selection. Use the filters below to access PCRonline resources.

Anatomy of the aortic valvar complex

View a detailed and comprehensive description of the anatomy of the aortic valvar complex as it pertains to TAVI.

View illustrated aortic valvar complex

Filtered By
TAVI

1365 results

Twenty years of progress - What we have achieved - LIVE case

27 Nov 2022 – From PCR London Valves 2022

  • Part 1: TAVI by axillary access (Live)
    An 80-year-old female with peripheral arterial disease presents a symptomatic severe aortic stenosis with small annulus and preserved LV function.
    The operators implant, by axillary access, an Evolut pro 26 mm, on general anaesthesia, with predilatation (Balloon 18 mm) and post-dilatation...
Twenty years of progress - What we have achieved

TAVI challenges: session 1

27 Nov 2022 – From PCR London Valves 2022

Discover a series of TAVI challenges shared by your peers: a transfemoral TAVR through a severely tortuous and horizontal aorta in a morbidly obese patient, TAVI for pure non-calcified severe aortic regurgitation in a large annulus, peripheral access calcifications and more.

TAVI challenges: session 1

TRISCEND, ACURATE neo2, the LuX-Valve System: Top Late-Breaking Trials from PCR London Vaves 2022

27 Nov 2022 – From PCR London Valves 2022

Discover a selection of PCR London Valves 2022 Late-Breaking Trial submissions and learn more about the latest evidence evidence concerning new transcatheter valve devices, emerging innovative devices as well as highlighted content from the EuroIntervention journal.

Top Late-Breaking Trials

DurAVR THV: Impact of Novel Leaflet Design on Hemodynamics & Transvalvular Physiology – FIH Results

Follow this dialogue between Bernard Prendergast, Christopher Meduri and João Cavalcante where they reflect on the journey in relation to transcatheter aortic valve implantation over the last 20 years and advances that can take us to a very bright and optimistic future - recorded for PCR...

DurAVR THV: Impact of Novel Leaflet Design on Hemodynamics & Transvalvular Physiology – FIH Results

The unmet need in severe aortic regurgitation: are we ready for TAVI?

The prevalence of valvular heart disease increases with advanced age and unfortunately, in many patients, it’s underdiagnosed, especially aortic regurgitation. In this presentation recorded for PCR London Valves 2022, Tanja Rudolph raises the question: are we ready for TAVR in aortic regurgitation?

View more videos and course...

The unmet need in severe aortic regurgitation: are we ready for TAVI?

A patient with severe aortic stenosis – how should I treat concomitant coronary artery disease?

31 Oct 2022

Discover the replay of this PCR Webinar on the Road in Verona, Italy on aortic stenosis with D. Milasinovic, C. de Biase and F. Ribichini.

A patient with severe aortic stenosis – how should I treat concomitant coronary artery disease?

A patient undergoing TAVI - how should I achieve optimal coronary access?

31 Oct 2022

Our duo of hosts Dejan Milasinovic and Chiara de Biase visit the cathlab of Khaled Al-Shaibi, based in Jeddah, Saudi Arabia.

A patient undergoing TAVI- how should we achieve optimal coronary access?

Bicuspid prevalence in China

31 Oct 2022

Discover the replay of this PCR webinar on TAVI with M. Chen, J. Kempfert, J.Z. Junjie, Y. Tang and Y. Wang.

Bicuspid prevalence in China

TAVI patients’ Lifetime Management: the unspoken consequences of Permanent Pacemaker Implantation

31 Oct 2022

Watch the replay of this webinar on TAVI with J. Rodés-Cabau, F. Saia and M. Ziacchi

TAVI patients’ Lifetime Management: the unspoken consequences of Permanent Pacemaker Implantation

Balloon- vs self-expanding valve systems for failed small surgical aortic valve bioprostheses

26 Oct 2022

Edoardo provides us with the cardiac surgeon's point of view!

The present trial aimed to clarify the hemodynamic results between balloon-expandable valve (BEV) (SAPIEN 3 ULTRA - Edwards) and self-expandable valve (SEV) (EVOLUT R/Pro/Pro+ - Medtronic) in case of dysfunctional small-sized surgical bio-prosthesis.

Edoardo Zancanaro

Reviewer

Edoardo Zancanaro
Balloon- vs self-expanding valve systems for failed small surgical aortic valve bioprostheses

Porcelain aorta, calcified aortic valve, and calcified left main: what comes first, the valve or the artery?

08 Nov 2022

How would you treat this 76-year-old male patient with severe AS symptomatic for angina, sinus rhythm with RBBB, previous bilateral CEA, and total occlusion of both the left CCA and the subclavian?

Author

Flavio Luciano Ribichini
Petros Dardas

Author

Petros Dardas
Beatriz Vaquerizo

Author

Beatriz Vaquerizo
Porcelain aorta, calcified aortic valve, and calcified left main: what comes first, the valve or the artery?

Abstracts - Coronary interventions - Session 4

07 Oct 2022 – From AICT-AsiaPCR 2022

Clinical cases - Structural interventions - Session 7

07 Oct 2022 – From AICT-AsiaPCR 2022

Clinical cases - Structural interventions - Session 9

07 Oct 2022 – From AICT-AsiaPCR 2022

Clinical cases - Structural interventions - Session 6

07 Oct 2022 – From AICT-AsiaPCR 2022

Optimising procedural outcomes of TAVI in challenging anatomies

06 Oct 2022

Watch the replay of this webinar on TAVI with N. Van Mieghem, D. Mylotte and M. Taramasso

Optimising procedural outcomes of TAVI in challenging anatomies

Lifetime management of patients with aortic stenosis

06 Oct 2022 – From AICT-AsiaPCR 2022

In this AICT-AsiaPCR 2022 session, review a ViV case to consider coronary occlusion and CT analysis, and examine a TAVI case to discuss failed TAVI bioprosthesis, so as to develop strategies for patients with AS and long-life expectancy.

Lifetime management of patients with aortic stenosis

Outcome of women in different cardiovascular interventions

06 Oct 2022 – From AICT-AsiaPCR 2022

Porcelain aorta, calcified aortic valve, and calcified left main. What comes first? Which valve?

05 Oct 2022

Watch the replay of this webinar to understand interpreting porcelain aorta, calcified aortic valve, and calcified left main...

Webinar - Porcelain aorta, calcified aortic valve, and calcified left main. What comes first? Which valve?

New-onset breathlessness following bioprosthetic surgical aortic valve replacement

26 Sep 2022

A 72-year-old female who had previously undergone surgical aortic valve replacement (sAVR), presents with a one-year history of NYHA II to III symptoms, particularly progressive over the past 3 months amounting to shortness of breath on minimal exertion...

Tiffany Patterson

Author

Tiffany Patterson
New-onset breathlessness following bioprosthetic surgical aortic valve replacement